The role of UICC and its members on Antimicrobial resistance

World Antimicrobial Awareness Week

World Antimicrobial Awareness Week (WAAW) is celebrated from 18-24 November every year to improve awareness and understanding of Antimicrobial resistance. The 2022 theme is 'Preventing Antimicrobial Resistance Together'. It encourages all sectors to use antimicrobials prudently and aims at strengthening preventive measures addressing AMR.

The threat of antimicrobial resistance (AMR) and its impact on cancer treatment is a priority for UICC. Currently, knowledge and awareness of the impact of AMR on cancer outcomes within the cancer community is low.  It is urgent that oncology professionals, cancer advocates, programme managers, patient groups and other stakeholders working in the field of cancer understand and address the factors that contribute to the development and spread of AMR and  work together to advocate for appropriate treatments,  surveillance systems and implementation of infection prevention and control.

In this regard, UICC provides information to increase awareness and supports the cancer community to drive policy change, taking forward the WHO global action plan on antimicrobial resistance adopted by the World Health Assembly in 2015, which outlines the following five objectives:

  1. Improve awareness and understanding of antimicrobial resistance through effective communication, education and training.
  2. Strengthen the knowledge and evidence base through surveillance and research.
  3. Reduce the incidence of infection through effective sanitation, hygiene and infection prevention measures.
  4. Optimise the use of antimicrobial medicines in human and animal health.
  5. Develop the economic case for sustainable investment that takes account of the needs of all countries and to increase investment in new medicines, diagnostic tools, vaccines and other interventions.

UICC leads a task force on AMR and its impact on cancer care outcomes. The task force includes experts from the infectious diseases and cancer communities. The objective of the taskforce is to guide our programme of work. 

The task force will showcase current evidence, identify research gaps in knowledge of cancer and AMR, share best practices, and ultimately engage the cancer community to collaborate and bring about policy change on addressing the threat of AMR.

UICC is committed to ensuring that AMR remains a priority globally and has highlighted the need to address AMR for better cancer care outcomes at the global health level. At the 74th World Health Assembly, UICC stressed the need for governments, the cancer community and infectious diseases communities to unite and raise awareness on AMR, share best practices for the rational use of antimicrobials and mobilize capacity building for R&D for new antimicrobials and diagnostics.

AMR Supplement

A supplement of AMR Control emphasising the impact of AMR on cancer care outcomes was launched at the World Cancer Congress 2022. Written by over 50 experts committed to researching the scale of AMR and to finding workable solutions, the supplement is an excellent reference for the cancer community as well as being a key resource for advocacy efforts.




With guidance from the taskforce and in collaboration with members, UICC has been active in raising awareness within the cancer community and beyond on the importance of addressing AMR through news and blogs, virtual learning activities, virtual dialogues, articles in science journals, and through social media (please see our resources hub for more).

Do you want to increase your knowledge and awareness about AMR?

Sign-up to UICC's self-guided course on addressing the threat of AMR for better cancer care outcomes.

This course is accredited by the Accreditation Council of Oncology in Europe (ACOE).

Open to all UICC members.

In the coming months, UICC will continue to raise awareness of AMR and highlight the importance of multisectoral collaboration in addressing this threat.  

Last update: 
Friday 11 November 2022